Peptika.
Legal · Patient consent

Patient consent.

Last updated · 2026-05-16In force · Version 1.0
Before issuing a magistral prescription, your physician requires your informed consent. This document explains, in plain terms, what you are consenting to when you start a Peptika protocol.

1 — Nature of the treatment

Magistral peptide preparations are individualised medicinal productscompounded specifically for you on the basis of an EU-licensed physician's prescription. They do not hold a Marketing Authorisation and are not advertised to the public. They are prescribed under Article 5(1) of Directive 2001/83/EC.

2 — Evidence base

The evidence base for each peptide is summarised in the product dossier shared by your physician. Many of the peptides we compound are supported by peer-reviewed clinical research; others are principally supported by preclinical research and clinical experience accumulated under magistral practice. Your physician discloses the evidence level for every peptide they prescribe to you.

3 — Side effects & risks

Like any medicine, peptide therapies can cause side effects. Possible adverse events depend on the molecule and include injection-site reactions, transient water retention, headaches, gastrointestinal symptoms, and rare allergic or immunological reactions. Your physician discusses your individual risk profile with you before prescription.

4 — Alternatives

You are entitled to be informed of the alternatives to a magistral peptide protocol, including licensed medicines, lifestyle interventions, and watchful waiting. Your physician must discuss these alternatives with you when clinically appropriate.

5 — Pregnancy, breastfeeding & specific conditions

Most peptide therapies are not appropriate during pregnancy or breastfeeding, in active cancer, or in patients with significant cardiac, hepatic or renal disease. Disclosure of all relevant medical history is required to allow your physician to assess appropriateness.

6 — Right to withdraw

You may withdraw consent at any time. Withdrawal stops compounding of any future preparation. Preparations already dispatched cannot be returned.

7 — Acknowledgement

By proceeding with a Peptika consultation you acknowledge that you have read this document, that you have had the opportunity to ask your physician any questions you may have, and that your consent is informed and freely given.

Need a clarification on this page? Patient support is available via the contact form.

See imprint & entity details